Thomas Anchordoquy
Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liposomes | 26 | 2024 | 224 | 5.260 |
Why?
| | DNA | 31 | 2018 | 1459 | 3.890 |
Why?
| | Gene Transfer Techniques | 12 | 2021 | 171 | 3.040 |
Why?
| | Nanoparticles | 11 | 2024 | 482 | 2.820 |
Why?
| | Cholesterol | 13 | 2019 | 410 | 2.670 |
Why?
| | Lipids | 19 | 2016 | 673 | 2.430 |
Why?
| | Polyethylene Glycols | 11 | 2024 | 641 | 2.260 |
Why?
| | Freeze Drying | 18 | 2014 | 84 | 2.240 |
Why?
| | Drug Carriers | 9 | 2024 | 128 | 2.180 |
Why?
| | Transfection | 21 | 2021 | 945 | 2.120 |
Why?
| | Plasmids | 17 | 2021 | 363 | 2.060 |
Why?
| | Neoplasms | 12 | 2023 | 2673 | 1.860 |
Why?
| | Nanomedicine | 4 | 2024 | 47 | 1.790 |
Why?
| | Exosomes | 5 | 2018 | 103 | 1.570 |
Why?
| | Quaternary Ammonium Compounds | 13 | 2014 | 52 | 1.320 |
Why?
| | Drug Delivery Systems | 7 | 2023 | 365 | 1.260 |
Why?
| | Fatty Acids, Monounsaturated | 12 | 2014 | 54 | 1.240 |
Why?
| | Particle Size | 17 | 2021 | 394 | 1.210 |
Why?
| | Nucleic Acids | 3 | 2015 | 71 | 1.160 |
Why?
| | Polymers | 4 | 2021 | 490 | 1.010 |
Why?
| | Doxorubicin | 3 | 2024 | 363 | 0.980 |
Why?
| | Cell Line, Tumor | 14 | 2024 | 3415 | 0.810 |
Why?
| | Interferons | 1 | 2024 | 202 | 0.810 |
Why?
| | Phosphatidylcholines | 5 | 2014 | 147 | 0.790 |
Why?
| | Chemistry, Pharmaceutical | 10 | 2014 | 105 | 0.770 |
Why?
| | Mice, Inbred BALB C | 7 | 2024 | 1272 | 0.760 |
Why?
| | Animals | 40 | 2024 | 36951 | 0.690 |
Why?
| | Receptor, ErbB-2 | 2 | 2014 | 341 | 0.680 |
Why?
| | COS Cells | 12 | 2009 | 188 | 0.660 |
Why?
| | DNA, Superhelical | 2 | 2011 | 11 | 0.660 |
Why?
| | Drug Stability | 11 | 2020 | 167 | 0.660 |
Why?
| | Phosphatidylethanolamines | 8 | 2014 | 77 | 0.640 |
Why?
| | Genetic Vectors | 5 | 2006 | 319 | 0.630 |
Why?
| | Tissue Distribution | 5 | 2021 | 332 | 0.630 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2019 | 14 | 0.610 |
Why?
| | Receptors, Fc | 1 | 2018 | 53 | 0.570 |
Why?
| | DNA, Circular | 2 | 2011 | 14 | 0.570 |
Why?
| | Carbohydrates | 4 | 2014 | 65 | 0.560 |
Why?
| | Cytokines | 3 | 2021 | 2085 | 0.560 |
Why?
| | Milk | 1 | 2018 | 124 | 0.560 |
Why?
| | Drug Storage | 3 | 2020 | 57 | 0.540 |
Why?
| | Blood Proteins | 3 | 2015 | 252 | 0.540 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 203 | 0.530 |
Why?
| | Freezing | 7 | 2014 | 90 | 0.530 |
Why?
| | Oligopeptides | 1 | 2019 | 271 | 0.520 |
Why?
| | Immunocompetence | 1 | 2016 | 42 | 0.520 |
Why?
| | Leukocytes | 1 | 2018 | 311 | 0.520 |
Why?
| | Mice | 16 | 2024 | 17794 | 0.510 |
Why?
| | Scattering, Radiation | 5 | 2010 | 101 | 0.500 |
Why?
| | Hemolysin Proteins | 2 | 2014 | 34 | 0.490 |
Why?
| | Spermine | 2 | 2006 | 27 | 0.480 |
Why?
| | Antineoplastic Agents | 5 | 2024 | 2129 | 0.480 |
Why?
| | Bacterial Toxins | 2 | 2014 | 106 | 0.470 |
Why?
| | Granulocytes | 1 | 2015 | 80 | 0.460 |
Why?
| | Heat-Shock Proteins | 2 | 2014 | 143 | 0.460 |
Why?
| | Sphingosine | 1 | 2014 | 46 | 0.440 |
Why?
| | Alkynes | 1 | 2014 | 56 | 0.440 |
Why?
| | Azides | 1 | 2014 | 46 | 0.440 |
Why?
| | Click Chemistry | 1 | 2014 | 49 | 0.430 |
Why?
| | Complement C3 | 1 | 2015 | 209 | 0.430 |
Why?
| | Calorimetry, Differential Scanning | 6 | 2013 | 37 | 0.420 |
Why?
| | Folic Acid | 2 | 2012 | 186 | 0.420 |
Why?
| | Ferrous Compounds | 1 | 2013 | 23 | 0.410 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 623 | 0.410 |
Why?
| | Microspheres | 2 | 2011 | 137 | 0.400 |
Why?
| | Water | 3 | 2011 | 461 | 0.390 |
Why?
| | Trace Elements | 1 | 2013 | 51 | 0.390 |
Why?
| | Surface Properties | 5 | 2017 | 413 | 0.380 |
Why?
| | Metals | 1 | 2013 | 136 | 0.370 |
Why?
| | Cations | 6 | 2014 | 84 | 0.360 |
Why?
| | Phospholipids | 1 | 2013 | 223 | 0.360 |
Why?
| | Luciferases | 4 | 2017 | 150 | 0.350 |
Why?
| | Reactive Oxygen Species | 3 | 2008 | 623 | 0.340 |
Why?
| | Surface-Active Agents | 2 | 2009 | 91 | 0.340 |
Why?
| | Biological Therapy | 1 | 2011 | 29 | 0.340 |
Why?
| | Bleomycin | 1 | 2012 | 248 | 0.340 |
Why?
| | Gold | 1 | 2011 | 118 | 0.330 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2024 | 128 | 0.320 |
Why?
| | L-Lactate Dehydrogenase | 3 | 2002 | 122 | 0.320 |
Why?
| | Models, Chemical | 1 | 2011 | 263 | 0.320 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2011 | 597 | 0.310 |
Why?
| | Cell Membrane | 1 | 2013 | 738 | 0.310 |
Why?
| | Genetic Therapy | 6 | 2014 | 297 | 0.310 |
Why?
| | MCF-7 Cells | 3 | 2014 | 124 | 0.300 |
Why?
| | Fluorescent Dyes | 4 | 2018 | 321 | 0.300 |
Why?
| | Humans | 33 | 2024 | 137782 | 0.300 |
Why?
| | Trehalose | 4 | 2014 | 32 | 0.280 |
Why?
| | Disease Models, Animal | 3 | 2021 | 4295 | 0.280 |
Why?
| | Liver | 2 | 2015 | 1943 | 0.270 |
Why?
| | Biological Availability | 2 | 2018 | 148 | 0.270 |
Why?
| | Nucleic Acid Conformation | 6 | 2009 | 728 | 0.260 |
Why?
| | Mice, Nude | 3 | 2017 | 698 | 0.260 |
Why?
| | Cell Line | 4 | 2014 | 2847 | 0.260 |
Why?
| | Ferric Compounds | 1 | 2006 | 56 | 0.250 |
Why?
| | Endosomes | 2 | 2021 | 136 | 0.250 |
Why?
| | Polydeoxyribonucleotides | 1 | 2006 | 14 | 0.250 |
Why?
| | Cattle | 3 | 2018 | 985 | 0.230 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2607 | 0.230 |
Why?
| | Dextrans | 1 | 2005 | 84 | 0.230 |
Why?
| | Spermidine | 1 | 2005 | 19 | 0.230 |
Why?
| | Extracellular Vesicles | 2 | 2018 | 146 | 0.220 |
Why?
| | Genes, Reporter | 2 | 2017 | 269 | 0.220 |
Why?
| | Sucrose | 4 | 2013 | 110 | 0.220 |
Why?
| | Polyesters | 1 | 2004 | 76 | 0.220 |
Why?
| | Ligands | 2 | 2019 | 664 | 0.210 |
Why?
| | Osmolar Concentration | 3 | 2013 | 171 | 0.210 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2253 | 0.200 |
Why?
| | Carbocyanines | 2 | 2018 | 33 | 0.200 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 144 | 0.200 |
Why?
| | Adsorption | 2 | 2013 | 149 | 0.190 |
Why?
| | Glioma | 2 | 2016 | 395 | 0.180 |
Why?
| | Vaccine Potency | 1 | 2020 | 6 | 0.180 |
Why?
| | Lupus Nephritis | 1 | 2021 | 63 | 0.170 |
Why?
| | Excipients | 3 | 2008 | 55 | 0.170 |
Why?
| | Vaccines, Synthetic | 1 | 2020 | 126 | 0.170 |
Why?
| | Polyethyleneimine | 3 | 2013 | 18 | 0.170 |
Why?
| | Lactose | 1 | 2020 | 7 | 0.170 |
Why?
| | Theranostic Nanomedicine | 1 | 2020 | 15 | 0.160 |
Why?
| | RNA, Small Interfering | 2 | 2013 | 622 | 0.160 |
Why?
| | Female | 9 | 2024 | 73465 | 0.160 |
Why?
| | Temperature | 2 | 2013 | 679 | 0.150 |
Why?
| | Nanotechnology | 1 | 2020 | 125 | 0.150 |
Why?
| | Toxicity Tests | 1 | 2019 | 37 | 0.150 |
Why?
| | Flow Cytometry | 2 | 2014 | 1178 | 0.150 |
Why?
| | Thiobarbituric Acid Reactive Substances | 2 | 2008 | 30 | 0.150 |
Why?
| | Oligonucleotides | 2 | 2011 | 148 | 0.150 |
Why?
| | Permeability | 1 | 2018 | 161 | 0.150 |
Why?
| | Solubility | 1 | 2018 | 245 | 0.140 |
Why?
| | Pentetic Acid | 2 | 2008 | 13 | 0.140 |
Why?
| | beta-Galactosidase | 1 | 1997 | 78 | 0.140 |
Why?
| | Drug Liberation | 1 | 2017 | 35 | 0.140 |
Why?
| | Chelating Agents | 2 | 2008 | 75 | 0.140 |
Why?
| | Mice, SCID | 1 | 2018 | 367 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2023 | 828 | 0.130 |
Why?
| | Electrophoresis, Agar Gel | 2 | 2008 | 26 | 0.130 |
Why?
| | Drug Compounding | 1 | 2017 | 101 | 0.130 |
Why?
| | Neoplasm Transplantation | 1 | 2017 | 257 | 0.130 |
Why?
| | Administration, Oral | 1 | 2018 | 816 | 0.120 |
Why?
| | Cell Survival | 3 | 2014 | 1120 | 0.120 |
Why?
| | Astrocytes | 1 | 2018 | 210 | 0.120 |
Why?
| | Ions | 1 | 2015 | 70 | 0.120 |
Why?
| | Tumor Burden | 1 | 2017 | 309 | 0.120 |
Why?
| | Nebulizers and Vaporizers | 2 | 2006 | 86 | 0.120 |
Why?
| | Proteins | 2 | 2017 | 1009 | 0.120 |
Why?
| | Circular Dichroism | 2 | 2006 | 149 | 0.120 |
Why?
| | Alanine Transaminase | 1 | 2015 | 157 | 0.120 |
Why?
| | Pharmaceutical Vehicles | 1 | 2014 | 12 | 0.120 |
Why?
| | Kinetics | 3 | 2005 | 1670 | 0.110 |
Why?
| | Glycerylphosphorylcholine | 1 | 2014 | 6 | 0.110 |
Why?
| | Buffers | 2 | 2013 | 56 | 0.110 |
Why?
| | Transition Temperature | 1 | 2014 | 26 | 0.110 |
Why?
| | Nephelometry and Turbidimetry | 2 | 2004 | 13 | 0.110 |
Why?
| | Urate Oxidase | 1 | 2014 | 11 | 0.110 |
Why?
| | Cycloaddition Reaction | 1 | 2014 | 28 | 0.110 |
Why?
| | DNA Damage | 2 | 2008 | 420 | 0.110 |
Why?
| | Drug Administration Schedule | 1 | 2016 | 786 | 0.110 |
Why?
| | Molecular Weight | 2 | 2005 | 335 | 0.110 |
Why?
| | Asparaginase | 1 | 2014 | 30 | 0.110 |
Why?
| | Injections, Intravenous | 1 | 2014 | 206 | 0.110 |
Why?
| | Time Factors | 4 | 2014 | 6834 | 0.110 |
Why?
| | Polylysine | 1 | 2014 | 17 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 2015 | 176 | 0.110 |
Why?
| | Glioblastoma | 1 | 2018 | 346 | 0.110 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2005 | 187 | 0.110 |
Why?
| | Copper | 1 | 2014 | 104 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 411 | 0.110 |
Why?
| | Contrast Media | 1 | 2017 | 467 | 0.100 |
Why?
| | Dendrimers | 1 | 2013 | 18 | 0.100 |
Why?
| | Choline | 1 | 2014 | 127 | 0.100 |
Why?
| | Cross-Linking Reagents | 1 | 2014 | 217 | 0.100 |
Why?
| | Tumor Microenvironment | 1 | 2018 | 676 | 0.100 |
Why?
| | Sulfites | 1 | 2013 | 7 | 0.100 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 434 | 0.100 |
Why?
| | Immune Tolerance | 1 | 2015 | 363 | 0.100 |
Why?
| | Drug Contamination | 1 | 2013 | 53 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 558 | 0.100 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.100 |
Why?
| | Antibodies | 1 | 2014 | 410 | 0.100 |
Why?
| | KB Cells | 1 | 2012 | 4 | 0.100 |
Why?
| | Cell Proliferation | 2 | 2018 | 2475 | 0.100 |
Why?
| | Luciferases, Firefly | 1 | 2012 | 3 | 0.100 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2004 | 177 | 0.100 |
Why?
| | Viruses | 1 | 2013 | 113 | 0.090 |
Why?
| | Binding Sites | 2 | 2006 | 1303 | 0.090 |
Why?
| | Sonication | 1 | 2011 | 13 | 0.090 |
Why?
| | Trastuzumab | 1 | 2012 | 96 | 0.090 |
Why?
| | Extracellular Space | 1 | 2012 | 119 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2005 | 560 | 0.090 |
Why?
| | Cytoplasm | 1 | 2012 | 274 | 0.090 |
Why?
| | Hydrodynamics | 1 | 2011 | 45 | 0.090 |
Why?
| | Vaccines, DNA | 1 | 2011 | 32 | 0.090 |
Why?
| | Thermodynamics | 2 | 2005 | 407 | 0.090 |
Why?
| | Cerebellar Neoplasms | 1 | 2012 | 152 | 0.080 |
Why?
| | Oligonucleotides, Antisense | 1 | 2011 | 112 | 0.080 |
Why?
| | Medulloblastoma | 1 | 2012 | 193 | 0.080 |
Why?
| | Immunotherapy | 1 | 2015 | 641 | 0.080 |
Why?
| | In Vitro Techniques | 3 | 2008 | 1092 | 0.080 |
Why?
| | DNA, Bacterial | 1 | 2011 | 337 | 0.080 |
Why?
| | Proteomics | 2 | 2016 | 1111 | 0.080 |
Why?
| | Humidity | 1 | 2009 | 50 | 0.080 |
Why?
| | Suspensions | 2 | 2008 | 36 | 0.080 |
Why?
| | Enzyme Stability | 2 | 2001 | 70 | 0.080 |
Why?
| | Stress, Mechanical | 1 | 2011 | 485 | 0.080 |
Why?
| | Methods | 1 | 2008 | 65 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 872 | 0.080 |
Why?
| | alpha-Tocopherol | 1 | 2008 | 33 | 0.070 |
Why?
| | Energy Transfer | 1 | 2008 | 46 | 0.070 |
Why?
| | Peptides | 1 | 2014 | 985 | 0.070 |
Why?
| | Ethidium | 1 | 2008 | 6 | 0.070 |
Why?
| | Clozapine | 1 | 2008 | 20 | 0.070 |
Why?
| | Methionine | 1 | 2008 | 160 | 0.070 |
Why?
| | Gelatin | 1 | 2008 | 52 | 0.070 |
Why?
| | Luminescence | 1 | 2008 | 38 | 0.070 |
Why?
| | Mice, Knockout | 1 | 2015 | 3018 | 0.070 |
Why?
| | Static Electricity | 2 | 2006 | 118 | 0.070 |
Why?
| | Serum | 1 | 2008 | 59 | 0.070 |
Why?
| | Rabbits | 2 | 2001 | 794 | 0.070 |
Why?
| | Fluorescamine | 1 | 2006 | 1 | 0.070 |
Why?
| | Phenanthrolines | 1 | 2006 | 7 | 0.070 |
Why?
| | Deferoxamine | 1 | 2006 | 24 | 0.070 |
Why?
| | Brain Neoplasms | 1 | 2016 | 1239 | 0.070 |
Why?
| | Iron Chelating Agents | 1 | 2006 | 18 | 0.070 |
Why?
| | Edetic Acid | 1 | 2006 | 50 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2015 | 1998 | 0.070 |
Why?
| | Escherichia coli | 1 | 2011 | 815 | 0.070 |
Why?
| | Indicators and Reagents | 1 | 2006 | 106 | 0.060 |
Why?
| | Protein Binding | 1 | 2013 | 2224 | 0.060 |
Why?
| | United States | 1 | 2024 | 14870 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2012 | 804 | 0.060 |
Why?
| | Light | 2 | 2001 | 381 | 0.060 |
Why?
| | Computer Simulation | 1 | 2011 | 982 | 0.060 |
Why?
| | Solutions | 1 | 2006 | 168 | 0.060 |
Why?
| | Titrimetry | 1 | 2006 | 12 | 0.060 |
Why?
| | Entropy | 1 | 2006 | 41 | 0.060 |
Why?
| | Calorimetry | 1 | 2006 | 70 | 0.060 |
Why?
| | Ultrasonics | 1 | 2006 | 49 | 0.060 |
Why?
| | Antipsychotic Agents | 1 | 2008 | 197 | 0.060 |
Why?
| | Hydrogen Bonding | 1 | 2006 | 163 | 0.060 |
Why?
| | Iron | 1 | 2008 | 313 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 976 | 0.060 |
Why?
| | Nucleic Acid Denaturation | 1 | 2005 | 32 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1430 | 0.060 |
Why?
| | Oxidation-Reduction | 1 | 2008 | 1060 | 0.060 |
Why?
| | Aerosols | 1 | 2006 | 176 | 0.060 |
Why?
| | Absorption | 1 | 2004 | 63 | 0.060 |
Why?
| | Molecular Structure | 1 | 2006 | 489 | 0.060 |
Why?
| | Behavior, Animal | 1 | 2008 | 501 | 0.050 |
Why?
| | Lung | 2 | 2015 | 4060 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 201 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 2006 | 179 | 0.050 |
Why?
| | Schizophrenia | 1 | 2008 | 439 | 0.050 |
Why?
| | Lactic Acid | 1 | 2004 | 305 | 0.050 |
Why?
| | Sodium Chloride | 1 | 2003 | 142 | 0.050 |
Why?
| | Shear Strength | 1 | 2002 | 67 | 0.050 |
Why?
| | Base Sequence | 1 | 2006 | 2181 | 0.050 |
Why?
| | Glycine | 1 | 2002 | 176 | 0.050 |
Why?
| | Phosphates | 1 | 2002 | 182 | 0.050 |
Why?
| | Salts | 1 | 2001 | 37 | 0.040 |
Why?
| | Imatinib Mesylate | 1 | 2021 | 79 | 0.040 |
Why?
| | Protein Structure, Quaternary | 1 | 2001 | 128 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1946 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 86 | 0.040 |
Why?
| | Surface Tension | 1 | 2000 | 8 | 0.040 |
Why?
| | Cell Movement | 2 | 2018 | 967 | 0.040 |
Why?
| | Mannitol | 1 | 2000 | 38 | 0.040 |
Why?
| | Isoenzymes | 1 | 2001 | 304 | 0.040 |
Why?
| | Protein Subunits | 1 | 2001 | 239 | 0.040 |
Why?
| | Muscles | 1 | 2001 | 326 | 0.040 |
Why?
| | RNA Stability | 1 | 2020 | 117 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2001 | 810 | 0.040 |
Why?
| | Cold Temperature | 1 | 2020 | 179 | 0.040 |
Why?
| | Models, Molecular | 1 | 2004 | 1570 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2002 | 811 | 0.040 |
Why?
| | Cation Exchange Resins | 1 | 1998 | 7 | 0.040 |
Why?
| | Swine | 1 | 2001 | 775 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 2002 | 1356 | 0.040 |
Why?
| | Povidone | 1 | 1996 | 5 | 0.030 |
Why?
| | Serum Albumin, Bovine | 1 | 1996 | 64 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2016 | 59 | 0.030 |
Why?
| | Myocardium | 1 | 2001 | 1002 | 0.030 |
Why?
| | Protein Array Analysis | 1 | 2015 | 57 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2015 | 4193 | 0.030 |
Why?
| | Kidney | 1 | 2021 | 1475 | 0.030 |
Why?
| | Interferon-alpha | 1 | 2014 | 198 | 0.030 |
Why?
| | Protein Conformation | 1 | 1996 | 934 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2016 | 739 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2020 | 2834 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2012 | 15 | 0.020 |
Why?
| | Glucose | 1 | 1997 | 1020 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2008 | 2487 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2003 | 86 | 0.020 |
Why?
| | Complement Activation | 1 | 2014 | 415 | 0.020 |
Why?
| | Rats | 2 | 2008 | 5648 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3196 | 0.020 |
Why?
| | 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2008 | 7 | 0.020 |
Why?
| | Injections, Intraventricular | 1 | 2008 | 55 | 0.020 |
Why?
| | beta-Cyclodextrins | 1 | 2008 | 28 | 0.020 |
Why?
| | Neurotoxicity Syndromes | 1 | 2008 | 25 | 0.020 |
Why?
| | Maze Learning | 1 | 2008 | 103 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2008 | 200 | 0.020 |
Why?
| | Reflex, Startle | 1 | 2008 | 65 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2008 | 92 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2008 | 94 | 0.020 |
Why?
| | Drug Design | 1 | 2008 | 167 | 0.020 |
Why?
| | Evoked Potentials, Auditory | 1 | 2008 | 180 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2008 | 312 | 0.020 |
Why?
| | Iodides | 1 | 2006 | 8 | 0.020 |
Why?
| | Genetic Techniques | 1 | 2006 | 64 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2008 | 886 | 0.010 |
Why?
| | NF-kappa B | 1 | 2008 | 691 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2006 | 688 | 0.010 |
Why?
| | Desiccation | 1 | 2003 | 19 | 0.010 |
Why?
| | Ammonium Sulfate | 1 | 2002 | 13 | 0.010 |
Why?
| | Male | 3 | 2021 | 67906 | 0.010 |
Why?
| | Protein Denaturation | 1 | 2002 | 74 | 0.010 |
Why?
| | Hippocampus | 1 | 2008 | 895 | 0.010 |
Why?
| | Crystallization | 1 | 2002 | 143 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5081 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2003 | 374 | 0.010 |
Why?
| | Glycerophospholipids | 1 | 2000 | 34 | 0.010 |
Why?
| | Colloids | 1 | 2000 | 60 | 0.010 |
Why?
| | Vibration | 1 | 2000 | 72 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2003 | 518 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2002 | 789 | 0.010 |
Why?
|
|
Anchordoquy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|